Cognitive impairment in schizophrenia involves a broad array of nonsocial and social
cognitive domains. It is a core feature of the illness, and one with substantial implications for …

Individuals with disorders that include psychotic symptoms (ie psychotic disorders)
experience broad cognitive impairments in the chronic state, indicating a dimension of …

Both the discovery of biomarkers of schizophrenia and the verification of biological
hypotheses of schizophrenia are an essential part of the process of understanding the …

A substantial and diverse body of literature suggests that the pathophysiology of
schizophrenia is related to deficits of bioenergetic function. While antipsychotics are an …

Background Evidence suggests that schizophrenia may be associated with an increased
risk of dementia, but results from prior studies have been inconsistent. This study aimed to …

Psychotic disorders are mental illnesses characterized by difficulties in reality testing. 1
Schizophrenia is a severe and chronic psychotic disorder with a lifetime prevalence of about …

Background Differences between people with schizophrenia and psychiatrically healthy
controls have been consistently demonstrated on measures of retinal function such as …

Characterizing neuroanatomical markers of different stages of schizophrenia (SZ) to assess
pathophysiological models of how the disorder develops is an important target for the …

Long non-coding RNAs (lncRNAs) are transcripts which are usually more than 200 nt in
length, and which do not have the protein-coding capacity. LncRNAs can be categorized …

In the last decades, the conceptualization of schizophrenia has dramatically changed,
moving from a neurodegenerative process occurring in early adult life to a …